KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Sales (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Return on Sales for 17 consecutive years, with 0.15% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 69.0% to 0.15% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15% through Dec 2025, down 17.0% year-over-year, with the annual reading at 0.15% for FY2025, 17.0% down from the prior year.
  • Return on Sales hit 0.15% in Q4 2025 for Abbott Laboratories, up from 0.14% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.84% in Q4 2024 to a low of 0.1% in Q4 2022.
  • Historically, Return on Sales has averaged 0.18% across 5 years, with a median of 0.15% in 2024.
  • Biggest five-year swings in Return on Sales: soared 69bps in 2024 and later plummeted -69bps in 2025.
  • Year by year, Return on Sales stood at 0.17% in 2021, then plummeted by -41bps to 0.1% in 2022, then surged by 52bps to 0.16% in 2023, then soared by 440bps to 0.84% in 2024, then crashed by -82bps to 0.15% in 2025.
  • Business Quant data shows Return on Sales for ABT at 0.15% in Q4 2025, 0.14% in Q3 2025, and 0.16% in Q2 2025.